Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.810
-0.120 (-4.10%)
Sep 16, 2026, 5:35 PM CET
Atrys Health Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 222 | 222 | 256 | 278 | 457 | 621 | |
Market Cap Growth | 3.88% | -13.13% | -8.07% | -39.03% | -26.47% | 107.99% |
Enterprise Value | 328 | 459 | 493 | 517 | 662 | 788 |
Last Close Price | 2.93 | 2.93 | 3.37 | 3.67 | 6.20 | 10.15 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 27.69 | 17.00 | 156.74 | 25.81 | 29.58 | 36.01 |
PS Ratio | 1.51 | 1.58 | 1.97 | 1.38 | 2.88 | 5.13 |
PB Ratio | 1.51 | 1.46 | 1.01 | 0.96 | 1.36 | 2.27 |
P/FCF Ratio | - | - | - | - | - | 1318.37 |
P/OCF Ratio | - | - | 85.39 | 48.85 | - | 132.29 |
PEG Ratio | - | 0.42 | 0.42 | 0.42 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.22 | 3.25 | 3.80 | 2.56 | 4.18 | 6.51 |
EV/EBITDA Ratio | 79.21 | 72.98 | 28.62 | 29.39 | 95.14 | 94.29 |
EV/FCF Ratio | - | - | - | - | - | 1672.26 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.80 | 1.70 | 1.01 | 0.88 | 0.72 | 0.73 |
Debt / EBITDA Ratio | 28.59 | 22.55 | 10.80 | 11.74 | 16.67 | 15.84 |
Debt / FCF Ratio | - | - | - | - | - | 425.85 |
Net Debt / Equity Ratio | 0.72 | 1.61 | 0.93 | 0.73 | 0.61 | 0.60 |
Net Debt / EBITDA Ratio | 424.04 | 38.85 | 13.61 | 12.03 | 29.46 | 19.80 |
Net Debt / FCF Ratio | -12.13 | -30.35 | -187.61 | -386.75 | -9.24 | 351.06 |
Asset Turnover | 0.33 | 0.26 | 0.21 | 0.30 | 0.25 | 0.32 |
Inventory Turnover | 64.70 | 62.74 | 64.39 | 103.08 | 115.91 | 123.85 |
Quick Ratio | 0.39 | 0.16 | 0.75 | 0.88 | 0.95 | 1.36 |
Current Ratio | 0.47 | 0.81 | 0.89 | 0.97 | 1.01 | 1.44 |
Return on Equity (ROE) | -24.57% | -27.46% | -12.07% | -9.82% | -8.51% | -13.43% |
Return on Assets (ROA) | -1.08% | -1.21% | -0.02% | -0.15% | -1.06% | -0.68% |
Return on Invested Capital (ROIC) | -3.05% | -2.35% | -0.03% | -0.30% | -2.19% | -1.43% |
Return on Capital Employed (ROCE) | -3.90% | -5.10% | 0.00% | -0.30% | -1.80% | -0.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -43.79% | -45.12% | -12.42% | -16.38% | -5.07% | -3.74% |
FCF Yield | -3.91% | -3.62% | -0.49% | -0.20% | -4.86% | 0.08% |
Buyback Yield / Dilution | 0.25% | 0.04% | -0.16% | -11.15% | -35.64% | -77.58% |